Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma
详细信息 查看全文
- 作者：Steffen Rausch ; Jörg Hennenlotter…
- 关键词：Biomarker ; Bladder cancer ; Immunohistochemistry ; Proliferation ; PTOV1
- 刊名：Journal of Cancer Research and Clinical Oncology
- 出版年：2016
- 出版时间：May 2016
- 年：2016
- 卷：142
- 期：5
- 页码：937-947
- 全文大小：1,246 KB
- 参考文献：Alana L et al (2014) Prostate tumor overexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Mol Cancer 13:74. doi:10.1186/1476-4598-13-74 CrossRef PubMed PubMedCentral
Benedit P et al (2001) PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene 20:1455–1464. doi:10.1038/sj.onc.1204233 CrossRef PubMed
Benzinger A, Muster N, Koch HB, Yates JR III, Hermeking H (2005) Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics (MCP) 4:785–795. doi:10.1074/mcp.M500021-MCP200 CrossRef
Bertz S et al (2014) Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. Eur Urol 65:218–226. doi:10.1016/j.eururo.2012.05.033 CrossRef PubMed
Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507:315–322. doi:10.1038/nature12965 CrossRef
Chen SP, Zhang LS, Fu BS, Zeng XC, Yi HM, Jiang N (2015) Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Medicine 94:e423. doi:10.1097/MD.0000000000000423 CrossRef PubMed PubMedCentral
Choi W, Czerniak B, Ochoa A, Su X, Siefker-Radtke A, Dinney C, McConkey DJ (2014a) Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer Nature reviews. Urology 11:400–410. doi:10.1038/nrurol.2014.129 PubMed
Choi W et al (2014b) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25:152–165. doi:10.1016/j.ccr.2014.01.009 CrossRef PubMed PubMedCentral
Damrauer JS et al (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci USA 111:3110–3115. doi:10.1073/pnas.1318376111 CrossRef PubMed PubMedCentral
Ferlay J et al (2015) Reprint of: cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 51:1201–1202. doi:10.1016/j.ejca.2015.05.004 CrossRef
Fernandez S et al (2011) PTOV1 is overexpressed in human high-grade malignant tumors. Virchows Archiv Int J Pathol 458:323–330. doi:10.1007/s00428-010-1018-1 CrossRef
Guo F, Feng L, Hu JL, Wang ML, Luo P, Zhong XM, Deng AM (2015) Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer. Tumour Biol J Int Soc Oncodev Biol Med 36:453–458. doi:10.1007/s13277-014-2662-x CrossRef
Hard RL, Liu J, Shen J, Zhou P, Pei D (2010) HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins. Biochemistry 49:10737–10746. doi:10.1021/bi101014s CrossRef PubMed PubMedCentral
Kirkali Z et al (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4–34. doi:10.1016/j.urology.2005.07.062 CrossRef PubMed
Lei F, Zhang L, Li X, Lin X, Wu S, Li F, Liu J (2014) Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. BMC Cancer 14:457. doi:10.1186/1471-2407-14-457 CrossRef PubMed PubMedCentral
Li M et al (2015) Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients. Tumour Biol J Int Soc Oncodev Biol Med. doi:10.1007/s13277-015-3130-y
Lotan Y et al (2013) Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy. Eur Urol 64:465–471. doi:10.1016/j.eururo.2013.03.043 CrossRef PubMed
Mangrud OM et al (2014) Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder. Hum Pathol 45:1496–1503. doi:10.1016/j.humpath.2014.03.001 CrossRef PubMed
Marques N et al (2014) Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Oncogene 33:1124–1134. doi:10.1038/onc.2013.51 CrossRef PubMed
Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R (2011) Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis Human pathology 42:1931–1936. doi:10.1016/j.humpath.2011.02.014 PubMed
McConkey DJ, Choi W, Dinney CP (2015) Genetic subtypes of invasive bladder cancer. Curr Opin Urol 25:449–458. doi:10.1097/MOU.0000000000000200 CrossRef PubMed
Morote J et al (2008) PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 14:2617–2622. doi:10.1158/1078-0432.CCR-07-4987 CrossRef PubMed
Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140PubMed
Santamaria A et al (2005) PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 25:1900–1911. doi:10.1128/MCB.25.5.1900-1911.2005 CrossRef PubMed PubMedCentral
Shariat SF et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–2422. doi:10.1016/j.juro.2006.08.004 (discussion 2422) CrossRef PubMed
Witjes JA et al (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65:778–792. doi:10.1016/j.eururo.2013.11.046 CrossRef PubMed - 作者单位：Steffen Rausch (1) (4)
Jörg Hennenlotter (1)
Marcus Scharpf (2)
Katharina Teepe (1)
Ursula Kühs (1)
Stefan Aufderklamm (1)
Simone Bier (1)
Johannes Mischinger (1)
Georgios Gakis (1)
Arnulf Stenzl (1)
Christian Schwentner (1)
Tilman Todenhöfer (1) (3)
1. Department of Urology, University Hospital, Tübingen, Germany
4. Department of Urology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Str. 4-6, 72076, Tübingen, Germany
2. Department of Pathology, University Hospital, Tübingen, Germany
3. Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Oncology
Cancer Research
Internal Medicine
Hematology - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-1335
文摘
Purpose To determine the expression patterns of the proliferation marker prostate tumor overexpressed 1 (PTOV1) in invasive urothelial cancer (UC).